Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Bladder cancer
Closed
Phase 2/3
This trial is looking at adding durvalumab to chemoradiotherapy for people with bladder cancer.
It is for people whose cancer has grown into the muscle wall. This is invasive bladder cancer.
Recruitment start: 1 August 2020
Recruitment end: 31 January 2025
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Nicholas James
AstraZeneca
University of Birmingham
Last reviewed: 31 January 2025
CRUK internal database number: 16901
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
